Decreases in psychiatric symptoms persist following exposure-based group therapy for sexual violence victimization among incarcerated women
2022 (English)In: Psychological Services, ISSN 1541-1559, Vol. 19, no 3, p. 534-540Article in journal (Refereed) Published
Abstract [en]
Survivors Healing from Abuse: Recovery through Exposure (SHARE) is a brief, exposure-based group treatment for incarcerated female survivors of sexual violence. Preliminary evaluations of SHARE showed declines in depression and posttraumatic stress disorder (PTSD) symptoms from pre- to posttreatment. However, prior investigations have not included a longitudinal follow-up period and thus knowledge of whether therapeutic benefits persist following the termination of the group is lacking. Here, we examined data from 57 incarcerated women who completed SHARE and provided follow-up data while still incarcerated (M = 95 days posttreatment). Results from a one-way repeated-measures ANOVA showed significant reductions in PTSD and depression symptoms from pre- to posttreatment (large effect sizes), with symptoms further reduced during the follow-up period. In addition, McNemar tests showed a significant reduction in the proportion of participants at or above the clinical cut-off for probable PTSD and depression from pre- to posttreatment as well as from posttreatment to the follow-up assessment. Together, results suggest that the therapeutic benefits of SHARE persist after treatment is completed. (PsycInfo Database Record (c) 2021 APA, all rights reserved)
Place, publisher, year, edition, pages
American Psychological Association (APA), 2022. Vol. 19, no 3, p. 534-540
Keywords [en]
Applied Psychology, Clinical Psychology, Evidence-based treatments, Interpersonal traumas, Sexual abuse, Trauma-focused treatments, Crime Victims, Female, Humans, Implosive Therapy, Prisoners, Psychotherapy, Group, Sex Offenses, Post-Traumatic Stress Disorders
National Category
Applied Psychology
Identifiers
URN: urn:nbn:se:mau:diva-46233DOI: 10.1037/ser0000570ISI: 000733021900001PubMedID: 34292004Scopus ID: 2-s2.0-85127235637OAI: oai:DiVA.org:mau-46233DiVA, id: diva2:1601704
2021-10-102021-10-102023-10-03Bibliographically approved